Molten Salt Solutions Raises $7 Million to Scale Lithium Isotope Production for Nuclear Energy

Molten Salt Solutions, a New Mexico-based lithium enrichment company, has closed an oversubscribed $7 million seed funding round led by Dolby Family Ventures, with participation from Vanedge Capital Partners, Alumni Ventures, Gaingels, True Ventures and Future Ventures. The funding will accelerate the company's transition from laboratory-validated technology to pilot-scale production of enriched lithium-6 and lithium-7 isotopes, fulfilling active customer agreements already in place.

 

Why Lithium-6 and Lithium-7 Serve Genuinely Different Reactor Technologies

 

The two isotopes this funding targets serve distinct nuclear technology pathways rather than a single application. Lithium-6 is required in large, reliable quantities for fusion energy systems, where it functions as a key material in the fuel cycle needed to sustain fusion reactions. Lithium-7, by contrast, is used specifically in advanced fission molten salt reactors, an entirely different nuclear technology that generates power through controlled fission reactions using a molten salt medium rather than fusion.

That distinction matters because it means Molten Salt Solutions' enrichment technology addresses two separate and independently developing segments of the advanced nuclear industry simultaneously, fusion energy companies and advanced fission reactor developers, rather than serving a single narrow customer base dependent on one specific reactor technology succeeding commercially. Given both fusion and advanced fission remain pre-commercial or early-commercial technologies still working toward broader deployment, serving both markets gives the company exposure to multiple potential paths to eventual large-scale demand rather than depending entirely on a single nuclear technology's commercial trajectory.

 

Read more: Nano One Reaffirms LFP Cathode Strategy as Demand Outside China Accelerates

 

Why the Domestic Supply Gap Carries Genuine Strategic Weight

 

The release states the United States currently lacks commercial-scale production of either lithium-6 or lithium-7, framing rebuilding domestic supply of both isotopes as "a recognized national priority for energy security." That framing reflects a broader pattern of concern around critical material supply chains for advanced energy technologies, comparable to concerns raised elsewhere in recent reporting about battery material processing capacity concentrated outside the United States, though in this specific case applied to isotope enrichment capability rather than battery materials.

Enrichment of specialized isotopes like these historically has required capital-intensive, technically sophisticated infrastructure that has concentrated in a small number of countries and facilities globally, meaning a domestic supply gap in either lithium isotope could create a genuine bottleneck constraining how quickly US-based fusion and advanced fission companies can scale their own technologies if they remain dependent on limited or foreign-sourced enriched lithium supply.

 

Why the Claimed Efficiency Improvement Is the Central Technical Claim Underpinning This Investment

 

The company describes its proprietary enrichment platform as "100X more efficient than legacy enrichment approaches," a claim that, if substantiated at genuine commercial scale, would represent the core technical differentiation justifying investor interest in this specific company over alternative approaches to lithium isotope production. Enrichment processes for isotopes like lithium-6 and lithium-7 have historically been energy-intensive and costly using conventional separation methods, and a claimed order-of-magnitude efficiency improvement would directly affect both the cost and the practical scalability of producing these materials at the volumes fusion and advanced fission industries would eventually require if those technologies reach broader commercial deployment.

That claim currently rests on the company's own laboratory-validated results rather than demonstrated pilot-scale commercial production, meaning this funding round specifically exists to test whether that laboratory-demonstrated efficiency advantage translates successfully into reliable, scaled production meeting the active customer agreements the company states it already holds.

 

Explore OneStop ESG Marketplace: Renewable Energy

 

What the Investor Composition Reveals About Sector-Specific Conviction

 

Several of the participating investors, including Alumni Ventures and Vanedge Capital Partners, describe active investment theses specifically targeting the nuclear and advanced energy sector, with Alumni Ventures citing prior investments in companies including X-Energy, Aalo Atomics, Radiant Nuclear and Valar Atomics, several of which are developing exactly the kind of advanced fission and fusion reactor technologies that would depend on the enriched lithium isotopes Molten Salt Solutions produces. That pattern suggests at least some of this round's investors bring not just capital but direct visibility into the broader advanced nuclear ecosystem's demand signals, having already invested in some of the reactor developers who would represent potential customers for enriched lithium supply.

This funding round follows the company's earlier $3 million pre-seed round and more than $5 million in grant funding, including support through New Mexico's Advanced Energy Award, giving Molten Salt Solutions a cumulative funding history exceeding $15 million prior to this latest raise as it works to move from laboratory validation toward genuine pilot-scale production capacity.

 

Source: Molten Salt Solutions